Murray N. Ross

发表

Cost and economic benefit of clinical decision support systems for cardiovascular disease prevention: a community guide systematic review

Nicolaas P. Pronk, Verughese Jacob, Anilkrishna B. Thota, 2017, J. Am. Medical Informatics Assoc..

New Drug Postmarketing Requirements and Commitments in the US: A Systematic Review of the Evidence

Jonathan J. Darrow, Murray N. Ross, A. Kesselheim, 2022, Drug Safety.

Evidence about Utilization and Expenditures Risk Segmentation Related to the Offering of a Consumer-DirectedHealth Plan: A Case Study of Humana Inc

Murray N. Ross, L. Tollen, S. Poor, 2004 .

Consumer-directed health care: it's not whether the glass is half-empty, but why.

Murray N. Ross, 2006, Health affairs.

Risk segmentation related to the offering of a consumer-directed health plan: a case study of Humana Inc.

Murray N. Ross, L. Tollen, S. Poor, 2004, Health services research.

Analysis of Supportive Evidence for US Food and Drug Administration Approvals of Novel Drugs in 2020

Jonathan J. Darrow, Murray N. Ross, A. Kesselheim, 2022, JAMA network open.

Gaps in residency training should be addressed to better prepare doctors for a twenty-first-century delivery system.

Murray N. Ross, F. Crosson, Jack Leu, 2011, Health affairs.

Patient Pathway Comparison for Total Hip Replacement in the United States and Germany — Why the Payment Model Matters

Murray N. Ross, M. Spoden, J. Convissar, 2023, NEJM Catalyst.

Something is amiss in Denmark: A comparison of preventable hospitalisations and readmissions for chronic medical conditions in the Danish Healthcare system and Kaiser Permanente

Murray N. Ross, F. Diderichsen, J. Søgaard, 2011, BMC health services research.

Addressing Health Care Market Reform Through an Insurance Exchange: Essential Policy Components, the Public Plan Option, and Other Issues to Consider

Murray N. Ross, P. Fronstin, 2009, EBRI issue brief.